Oxea increases manufacturing capacity

Syngas is the key precursor for the production of oxo intermediates and oxo derivatives, which are used in pharmaceutical products.

The manufacturing facility develops oxo chemicals, synthetic fatty acids, and acetate esters.

Oxea Executive Board member for marketing and sales Miguel Mantas said higher product availability of oxo products will further lead to an improved level of service and supply security for the customers

Following capacity expansion in the US, the compant intends to further establish itself in the dynamic growth market of oxo-intermediates and oxo-derivatives.